The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes
Article 2018 en
Authors
AS
Abdel Aziz Shaheen
GK
Gilaad G. Kaplan
WA
Wagdi Almishri
Abstract
1 min read
In our study, depression was not associated with poor clinical outcomes. However, using the antidepressant mirtazapine was associated with decreased mortality, decompensated cirrhosis and liver transplantation in PBC patients. These findings support further assessment of mirtazapine as a potential treatment for PBC patients.
Elena Dragioti, Joaquim Raduà, Marco Solmi, Corentin J. Gosling, Dominic Oliver, Filippo Lascialfari, Muhammad Ahmed, Samuele Cortese, Andrés Estradé, Gonzalo Arrondo, M. Gouva, Michele Fornaro, A. L. Batiridou, Konstantina Dimou, D Tsartsalis, André F. Carvalho, Jae Il Shin, Michael Berk, Silvia Stringhini, Christoph U. Correll, Paolo Fusar‐Poli
Marco Solmi, Alessandro Miola, Giovanni Croatto, Giorgio Pigato, Angela Favaro, Michele Fornaro, Michael Berk, Lee Smith, João Quevedo, Michael Maes, Christoph U. Correll, André F. Carvalho
Discussion(0)
No comments yet. Be the first to comment.